Immunodiagnosticum for Detection of Hepatitis B Virus Antigen

Immunodiagnosticum for detecting hepatitis B virus antigen

Hepatitis B virus (HBV) is one of the most common viral liver diseases that can lead to chronic infection, cirrhosis and even liver cancer. Timely detection and diagnosis of hepatitis B virus is key to preventing the spread of infection and providing effective treatment.

Immunodiagnosticum for the detection of hepatitis B virus antigen is a diagnostic tool designed to determine the presence of HBsAg (hepatitis B virus surface antigen) in the patient's body. HBsAg is a key marker of active HBV infection and can be detected in a patient's blood early in the disease, even before clinical symptoms appear.

Immunodiagnosticum is produced by several Russian pharmaceutical companies, including Microgen NPO and the Nizhny Novgorod enterprise for the production of bacterial preparations-Imbio. It is a red blood cell (HBsAg) dry reagent kit that contains antibodies that specifically bind to HBsAg. When antibodies interact with an antigen, a visible complex is formed, which makes it possible to visually determine the presence of HBsAg in a blood sample.

The immunodiagnosticum for detecting hepatitis B virus antigen provides a simple and rapid way to diagnose HBV infection. It can be used in laboratory settings, including clinical laboratories and health care settings, to screen patients for the presence of hepatitis B virus. Test results can be obtained in a short time, which